The National Institutes of Health (NIH) are funding R21 exploratory/development research grants that propose small scale or pilot and feasibility clinical and translational research studies, including epidemiological studies or clinical trials related to kidney disease research. Studies should address important clinical and translational questions and are potentially of high clinical and public health impact. These grants will award up to $275,000 over two years. The deadline for the next funding cycle is September 7. Read the full announcement.
NIH Offering R21 Pilot and Feasibility Clinical Research Grants in Kidney Diseases (due September 7)
NIH Announcements
- Examining the Impact of Artificial Intelligence (AI) on Healthcare Safety (R18)
- Notice of Need to Expire and Reissue PAR-24-090 "Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative UG3/UH3 Clinical Trial Required)"
- Notice of Need to Expire and Reissue PAR-24-087 "Data Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative U24 Clinical Trial Required)"
